Tyrosine kinase inhibitors and multidrug resistance proteins: interactions and biological consequences
Amalia Azzariti(Istituto Tumori Bari), Angelo Paradiso(Universidad de Oviedo), Letizia Porcelli(Istituto Tumori Bari), Roberto Perrone(University of Bari Aldo Moro), Maurizio D’Incalci(Humanitas University), Massimo Zucchetti(Mario Negri Institute for Pharmacological Research), G. Simone(University of Bari Aldo Moro), Francesco Berardi(University of Bari Aldo Moro), Nicola Antonio Colabufo(University of Bari Aldo Moro), Anna Elisa Quatrale, Jian Xu(University of California, Los Angeles)
Cited by 50
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
|Gastric Cancer|2014|615
Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis
|Molecular Carcinogenesis|2010|558
Drug resistance to targeted therapeutic strategies in non-small cell lung cancer
|Pharmacology & Therapeutics|2019|245
Basic principles of biobanking: from biological samples to precision medicine for patients
|Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin|2021|223